| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A F Breier, A K Malhotra, T P Su, D A Pinals, I Elman, C M Adler, R T Lafargue, A Clifton, D Picka. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. The American journal of psychiatry. vol 156. issue 2. 1999-02-25. PMID:9989566. |
clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. |
1999-02-25 |
2023-08-12 |
Not clear |
| A F Breier, A K Malhotra, T P Su, D A Pinals, I Elman, C M Adler, R T Lafargue, A Clifton, D Picka. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. The American journal of psychiatry. vol 156. issue 2. 1999-02-25. PMID:9989566. |
clozapine and risperidone were the first two "second-generation" antipsychotic drugs approved for schizophrenia. |
1999-02-25 |
2023-08-12 |
Not clear |
| C R Young, M B Bowers, C M Mazur. Management of the adverse effects of clozapine. Schizophrenia bulletin. vol 24. issue 3. 1999-02-22. PMID:9718630. |
clozapine has been found to be superior to traditional neuroleptics in the treatment of refractory schizophrenia and is increasingly being used to treat schizophrenia, affective disorders, some neurological disorders, and aggression. |
1999-02-22 |
2023-08-12 |
Not clear |
| R A Dickson, J T Dalby, R Williams, S J Warde. Hospital days in clozapine-treated patients. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 43. issue 9. 1999-02-22. PMID:9825168. |
to examine inpatient hospital days used by a group of patients with treatment-resistant schizophrenia for 3 years before and 3 years after clozapine initiation. |
1999-02-22 |
2023-08-12 |
Not clear |
| C Guitton, M Abbar, J M Kinowski, P Chabrand, F Bressoll. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia. Journal of clinical psychopharmacology. vol 18. issue 6. 1999-02-18. PMID:9864080. |
multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia. |
1999-02-18 |
2023-08-12 |
Not clear |
| C Guitton, M Abbar, J M Kinowski, P Chabrand, F Bressoll. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia. Journal of clinical psychopharmacology. vol 18. issue 6. 1999-02-18. PMID:9864080. |
the pharmacokinetic parameters of clozapine and its two main metabolites, n-desmethylclozapine (norclozapine, active metabolite) and clozapine n-oxide, were evaluated, after oral administration, in 19 patients with chronic schizophrenia. |
1999-02-18 |
2023-08-12 |
Not clear |
| M J Travis, G F Busatto, L S Pilowsky, R Mulligan, P D Acton, S Gacinovic, J Mertens, D Terrière, D C Costa, P J Ell, R W Kerwi. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. The British journal of psychiatry : the journal of mental science. vol 173. 1999-02-09. PMID:9926100. |
5-ht2a receptor blockade in patients with schizophrenia treated with risperidone or clozapine. |
1999-02-09 |
2023-08-12 |
Not clear |
| M L Lee, R A Dickson, M Campbell, J Oliphant, H Gretton, J T Dalb. Clozapine and substance abuse in patients with schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 43. issue 8. 1999-02-08. PMID:9806095. |
clozapine and substance abuse in patients with schizophrenia. |
1999-02-08 |
2023-08-12 |
Not clear |
| D P Bassitt, M R Louzã Net. Clozapine efficacy in tardive dyskinesia in schizophrenic patients. European archives of psychiatry and clinical neuroscience. vol 248. issue 4. 1999-02-05. PMID:9810484. |
in an open trial seven patients with schizophrenia and severe td were given clozapine for 6 months. |
1999-02-05 |
2023-08-12 |
Not clear |
| C Fleischhaker, E Schulz, H Remschmid. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia. Journal of psychiatric research. vol 32. issue 5. 1999-01-29. PMID:9789212. |
biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia. |
1999-01-29 |
2023-08-12 |
human |
| C Fleischhaker, E Schulz, H Remschmid. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia. Journal of psychiatric research. vol 32. issue 5. 1999-01-29. PMID:9789212. |
the purpose of the present study was to assess the relationship between plasma monoamine levels and changes in psychopathology in a sample of children and adolescents with schizophrenia (dsm-iii-r criteria) during conventional neuroleptic therapy and during short-term treatment with clozapine. |
1999-01-29 |
2023-08-12 |
human |
| D Umbricht, D Javitt, G Novak, J Bates, S Pollack, J Lieberman, J Kan. Effects of clozapine on auditory event-related potentials in schizophrenia. Biological psychiatry. vol 44. issue 8. 1999-01-29. PMID:9798075. |
effects of clozapine on auditory event-related potentials in schizophrenia. |
1999-01-29 |
2023-08-12 |
Not clear |
| R Rosenheck, L Dunn, M Peszke, J Cramer, W Xu, J Thomas, D Charne. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The American journal of psychiatry. vol 156. issue 1. 1999-01-27. PMID:9892302. |
impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. |
1999-01-27 |
2023-08-12 |
Not clear |
| R Rosenheck, L Dunn, M Peszke, J Cramer, W Xu, J Thomas, D Charne. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The American journal of psychiatry. vol 156. issue 1. 1999-01-27. PMID:9892302. |
department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. |
1999-01-27 |
2023-08-12 |
Not clear |
| R Rosenheck, L Dunn, M Peszke, J Cramer, W Xu, J Thomas, D Charne. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The American journal of psychiatry. vol 156. issue 1. 1999-01-27. PMID:9892302. |
this study compared the effect of clozapine and haloperidol on positive and negative symptoms of schizophrenia and in patients with high levels of negative symptoms or the deficit syndrome. |
1999-01-27 |
2023-08-12 |
Not clear |
| S G Potkin, Y Jin, B G Bunney, J Costa, B Gulasekara. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. The American journal of psychiatry. vol 156. issue 1. 1999-01-27. PMID:9892314. |
effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. |
1999-01-27 |
2023-08-12 |
Not clear |
| S G Potkin, Y Jin, B G Bunney, J Costa, B Gulasekara. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. The American journal of psychiatry. vol 156. issue 1. 1999-01-27. PMID:9892314. |
the focus of this study was the systematic evaluation of the clinical effects of glycine as an adjunct to the atypical antipsychotic clozapine in the treatment of schizophrenia. |
1999-01-27 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, W Xu, J Grabowski, R Douyon, J Thomas, W Henderson, D Charne. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Health services research. vol 33. issue 5 Pt 1. 1999-01-07. PMID:9865219. |
multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. |
1999-01-07 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, W Xu, J Grabowski, R Douyon, J Thomas, W Henderson, D Charne. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Health services research. vol 33. issue 5 Pt 1. 1999-01-07. PMID:9865219. |
department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. |
1999-01-07 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, W Xu, J Grabowski, R Douyon, J Thomas, W Henderson, D Charne. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Health services research. vol 33. issue 5 Pt 1. 1999-01-07. PMID:9865219. |
to develop new methods for combining results from multiple outcome domains and to demonstrate their application in a study of the cost-effectiveness of clozapine in treating hospitalized patients with refractory schizophrenia. |
1999-01-07 |
2023-08-12 |
Not clear |